Clinical Trials
EYLEA HD® Phase 3 Trial Yields Promising Results
Regeneron Pharmaceuticals, Inc. announced promising results from the Phase 3 QUASAR trial investigating EYLEA HD® (aflibercept) Injection 8 mg for treating macular edema in patients...
Clinical Trials
Pfizer’s BRAFTOVI Improves Survival in Phase 3 Trial
Pfizer has announced groundbreaking results from the Phase 3 BREAKWATER trial, showcasing the effectiveness of its BRAFTOVI® (encorafenib) combination regimen in the treatment of metastatic...
Clinical Trials
VerZom achieves first bioproduction of clinical grade stem cell-derived exosomes in large scale bioreactors in partnership with the EFS with unprecedented yields
EVerZom, a biopharmaceutical company developing exosome based biodrugs, announces that it has reached a key milestone in its development with the production of a first exosome GMP batch in a 10L bioreactor with unprecedented...
Clinical Trials
New Endometrial Cancer Therapy Phase-II Trial Shows Promise
The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for patients...
Clinical Trials
Duality Looks Out For Hong Kong IPO To Finance ADC Trials
Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an undisclosed...
Clinical Trials
PhotonPharma Secures $2.5 Million in Seed Funding to Advance Clinical Trial for Ovarian Cancer Treatment
PhotonPharma, a cutting-edge biopharmaceutical company based in Fort Collins, Colorado, is pleased to announce the successful closing of a $2.5 million seed financing round. This...
Clinical Trials
Biotechs Recursion, Exscientia Merge For $850M And 10 Trials
The resultant biotech, which the businesses announced on Thursday, would have a pipeline that may produce 10 clinical readouts over the next 18 months, with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.